Fundraising Fox

Verdiva Bio

77 employees on LinkedIn · 2 known investors

Verdiva Bio is a biotechnology company focused on drug development. Its leadership brings experience in in-licensing, commercialization, and business development across the international biotech industry.

BiotechHealthtech

Founders & leadership

JHJane Hughes
Jane HughesinChief Scientific Officer
KFKhurem Farooq
Khurem FarooqinChief Executive Officer

Investors · 2

OrbiMedNew York · $1M – $75M
RA CapitalBoston

Funding

SEC filings, press & company announcements

$410M disclosed across 1 round · 2025

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Verdiva Bio Raises Over $410M in Series A Financingfinsmes.com · Jan 2025Verdiva Bio: Cardiometabolic Company Raises Over $410 Million (Series A)pulse2.com · Jan 2025Verdiva Bio launches with $411M Series A raise for next-gen oral and injectable treatments for obesity - Tech.eutech.eu · Jan 2025Verdiva Bio, a New Clinical-Stage Cardiometabolic Company, Launches with Over $410M in Series A Financing to Advance Next-Generation Therapies | General Atlanticgeneralatlantic.com · Jan 2025

Frequently asked questions

What does Verdiva Bio do?
Verdiva Bio is a biotechnology company focused on drug development. Its leadership brings experience in in-licensing, commercialization, and business development across the international biotech industry.
Who are Verdiva Bio's investors?
Verdiva Bio's investors include OrbiMed, RA Capital.
How much funding has Verdiva Bio raised?
Verdiva Bio has disclosed $410M raised across 1 round.